Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A new study suggests that changes in two heat-shock protein genes — HSPA1A and HSPA1L — may signal how severe acute pancreatitis will become. Patients with a specific HSPA1L gene variant showed more than double the gene activity, especially in the most severe cases. Researchers say these genetic markers could one day serve as early prognostic tools for a condition that currently has no dedicated treatment.
Acute pancreatitis (AP) is a potentially life-threatening digestive condition with no dedicated treatment — and predicting who will get the worst of it remains a challenge. A new prospective study published in Pancreas suggests that two genes in the heat-shock protein 70 (HSP70) family, HSPA1A and HSPA1L, may hold clues about disease severity before it fully unfolds.
Researchers at Georgetown University Hospital analyzed blood samples from 43 AP patients and 47 healthy controls, measuring gene activity and genetic variants using quantitative PCR. They found that HSPA1A activity dropped significantly in patients with mild-to-moderate disease, while a specific variant of HSPA1L (the AG version) was associated with more than double the gene activity compared to the common AA version — a pattern most pronounced in the severest cases.
Key Takeaways:
Why it matters: With no targeted therapies for AP, identifying reliable genetic biomarkers could transform how clinicians stratify risk and personalize care — though larger studies are needed to validate these findings.
